ENVELOPE PROTEIN AND P18(IIIB) PEPTIDE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES FROM HUMANS IMMUNIZED WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE

Citation
A. Achour et al., ENVELOPE PROTEIN AND P18(IIIB) PEPTIDE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES FROM HUMANS IMMUNIZED WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE, Vaccine, 11(7), 1993, pp. 699-701
Citations number
16
Categorie Soggetti
Immunology
Journal title
ISSN journal
0264410X
Volume
11
Issue
7
Year of publication
1993
Pages
699 - 701
Database
ISI
SICI code
0264-410X(1993)11:7<699:EPAPPR>2.0.ZU;2-N
Abstract
Cytotoxic T cells are the main antigen-specific effector cells of the cellular immune system and MHC class I restricted cytotoxic T-lymphocy te (CTL) responses in mice, acting against the HIV-1 envelope protein, are known to be predominantly directed against an amino acid sequence in the third hypervariable domain. We have investigated the epitope s pecificity of anti-HIV-1 CTL in healthy human volunteers inoculated wi th a recombinant vaccinia expressing the HIV-1 gp160 envelope gene. Th eir isolated lymphocytes were stimulated in vitro with autologous HIV- 1 infected cells. Our results show that immunization with recombinant virus is able to generate virus-specific CTLs to the HIV-1 gp160 envel ope protein and to a 15-residue synthetic peptide corresponding to a h ighly variable region of the envelope p18(IIIB). The CTL response was restricted by class I MHC molecules HLA-A2 and A3 that commonly occur in the human population.